Compare MPU & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MPU | HYFT |
|---|---|---|
| Founded | 1989 | 1983 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.9M | 80.8M |
| IPO Year | 1998 | 2017 |
| Metric | MPU | HYFT |
|---|---|---|
| Price | $1.30 | $1.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 183.4K | ★ 320.4K |
| Earning Date | 11-12-2025 | 12-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $31,139,100.00 | $18,214,531.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $71.78 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 19.76 | 18.33 |
| 52 Week Low | $0.49 | $0.27 |
| 52 Week High | $4.44 | $3.25 |
| Indicator | MPU | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 60.55 | N/A |
| Support Level | $0.98 | N/A |
| Resistance Level | $1.34 | N/A |
| Average True Range (ATR) | 0.13 | 0.00 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 84.62 | 0.00 |
Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.